tiprankstipranks
SpringWorks Therapeutics announces EMA validaion for nirogacestat MAA
PremiumThe FlySpringWorks Therapeutics announces EMA validaion for nirogacestat MAA
2M ago
SpringWorks Therapeutics Announces European Medicines Agency Validation for Marketing Authorization Application of Nirogacestat for the Treatment of Adults with Desmoid Tumors
PremiumPress Releases
SpringWorks Therapeutics Announces European Medicines Agency Validation for Marketing Authorization Application of Nirogacestat for the Treatment of Adults with Desmoid Tumors
2M ago
SpringWorks Therapeutics price target raised to $63 from $47 at Barclays
PremiumThe Fly
SpringWorks Therapeutics price target raised to $63 from $47 at Barclays
2M ago
SpringWorks Therapeutics to Present at Upcoming Investor Conferences
PremiumPress ReleasesSpringWorks Therapeutics to Present at Upcoming Investor Conferences
2M ago
SpringWorks Therapeutics to Present at Upcoming Investor Conferences
PremiumPress Releases
SpringWorks Therapeutics to Present at Upcoming Investor Conferences
2M ago
SpringWorks Therapeutics CDO Resigns, Assumes Advisory Role
PremiumCompany Announcements
SpringWorks Therapeutics CDO Resigns, Assumes Advisory Role
3M ago
SpringWorks Therapeutics Highlights 2023 Accomplishments and Anticipated Milestones for 2024 at the 42nd Annual J.P. Morgan Healthcare Conference
PremiumPress ReleasesSpringWorks Therapeutics Highlights 2023 Accomplishments and Anticipated Milestones for 2024 at the 42nd Annual J.P. Morgan Healthcare Conference
3M ago
SpringWorks Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
PremiumPress Releases
SpringWorks Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
4M ago
SpringWorks Therapeutics Announces Closing of Upsized Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
PremiumPress Releases
SpringWorks Therapeutics Announces Closing of Upsized Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100